Host T cells affect donor T cell engraftment and graft-versus-host disease after reduced-intensity hematopoietic stem cell transplantation
about
Pentostatin plus cyclophosphamide safely and effectively prevents immunotoxin immunogenicity in murine hosts.Phase I trial of adoptive cell transfer with mixed-profile type-I/type-II allogeneic T cells for metastatic breast cancer.Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomasThe development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation.Favorable outcomes in patients with high donor-derived T cell count after in vivo T cell-depleted reduced-intensity allogeneic stem cell transplantation.
P2860
Host T cells affect donor T cell engraftment and graft-versus-host disease after reduced-intensity hematopoietic stem cell transplantation
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 July 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Host T cells affect donor T ce ...... etic stem cell transplantation
@en
Host T cells affect donor T ce ...... tic stem cell transplantation.
@nl
type
label
Host T cells affect donor T ce ...... etic stem cell transplantation
@en
Host T cells affect donor T ce ...... tic stem cell transplantation.
@nl
prefLabel
Host T cells affect donor T ce ...... etic stem cell transplantation
@en
Host T cells affect donor T ce ...... tic stem cell transplantation.
@nl
P2093
P2860
P1476
Host T cells affect donor T ce ...... etic stem cell transplantation
@en
P2093
Daniel H Fowler
Frances Hakim
Jeanne Odom
Michael R Bishop
Nancy M Hardy
Rebecca Babb
Romana Cvitkovic
Ronald E Gress
Seth M Steinberg
P2860
P304
P356
10.1016/J.BBMT.2007.05.008
P577
2007-07-16T00:00:00Z